Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

  • Post published:December 1, 2020
  • Post category:Press Release
Read more about the article Entheon Biomedical to Begin Trading on the Frankfurt Exchange

Entheon Biomedical to Begin Trading on the Frankfurt Exchange

  • Post published:November 26, 2020
  • Post category:Press Release
Read more about the article Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange

Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange

  • Post published:November 12, 2020
  • Post category:Press Release
Read more about the article Entheon to List on CSE on or about Nov 12th Under Symbol ENBI

Entheon to List on CSE on or about Nov 12th Under Symbol ENBI

  • Post published:November 6, 2020
  • Post category:Press Release
Read more about the article Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

  • Post published:October 28, 2020
  • Post category:Press Release
Read more about the article MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp. and Financing

MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp. and Financing

  • Post published:July 3, 2020
  • Post category:Press Release
Read more about the article Interview with Timothy Ko, CEO, Entheon

Interview with Timothy Ko, CEO, Entheon

  • Post published:May 29, 2020
  • Post category:Interview
Read more about the article Private Financing: Entheon Biomedical

Private Financing: Entheon Biomedical

  • Post published:May 7, 2020
  • Post category:Private Financing

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More